Abstract
Computational methods play a key role in the design of therapeutically important molecules for modern drug development. With these “in silico” approaches, machines are learning and offering solutions to some of the most complex drug related problems and has well positioned them as a next frontier for potential breakthrough in drug discovery. Machine learning (ML) methods are used to predict compounds with pharmacological activity, specific pharmacodynamic and ADMET (absorption, distribution, metabolism, excretion and toxicity) properties to evaluate the drugs and their various applications. Modern artificial intelligence (AI) has the capacity to significantly enhance the role of computational methodology in drug discovery. Use of AI in drug discovery and development, drug repurposing, improving pharmaceutical productivity, and clinical trials will certainly reduce the human workload as well as achieving targets in a short period of time. This chapter elaborates the crosstalk between the machine learning techniques, computational tools and the future of AI in the pharmaceutical industry.
Reference48 articles.
1. Jorgensen WL (2004) The many roles of computation in drug discovery. Science 303(5665):1813. DOI: https://doi.org/10.1126/scien ce.1096361.
2. Aminpour M, Montemagno C, Tuszynski JA (2019) An overview of molecular modeling for drug siscovery with specifc illustrative examples of applications. Molecules 24(9):1693. DOI: https://doi. org/10.3390/molecules24091693.
3. Parr, R. G. and Yang, W. Density Functional Theory of Atoms and Molecules, Oxford University Press, Oxford, 1989.
4. Kohn, W. Becke, A. D. and Parr, R. G. (1996) Density Functional Theory of Electronic Structure. J. Phys. Chem., 100, 12974-12980. DOI: 10.1021/JP960669L.
5. Ayers, P. W. and Yang, W. Density Functional Theory, in Computational Medicinal Chemistry for Drug Discovery, ed., P. Bultinck, H. de Winter, W. Langenaeker and J. P. Tollenaere, Dekker, New York, 2003, p. 571.